ASX 200 closes marginally higher; materials leads gain, A-REIT falls

September 27, 2022 04:30 PM AEST | By Bhawna Gupta
 ASX 200 closes marginally higher; materials leads gain, A-REIT falls
Image source: © Woodhouse84 | Megapixl.com

Highlights:

  • The ASX 200 benchmark index closed up today, gaining 0.41% to end at 6,496.20 points.
  • Over the last five days, the index has lost 4.56% and has shed 12.03% over the last 52 weeks.
  • Materials was the best performing sector, closing 2.57% higher.
  • A-REIT was the worst performing sector today, losing 2.17%.

The S&P/ASX200 closed higher on Tuesday (27 September), gaining 26.80 points or 0.41% to end at 6,496.20 points.

Key pointers from ASX close today

  • The ASX 200 benchmark index closed up today, gaining 26.80 points or 0.41% to end at 6,496.20 points.
  • Brainchip Holdings Ltd (ASX:BRN) and Whitehaven Coal Ltd (ASX:WHC), gained up 7.23% and 6.83% respectively respectively.
  • Bottom performing stocks in this index were Core Lithium Ltd (ASX:CXO) and Fisher & Paykel Healthcare Corp Ltd (ASX:FPH), ending 5.56% and 4.75% lower respectively.
  • Over the last five days, the index has lost 4.56% and 12.03% over the last 52 weeks.
  • Seven out of 11 sectors closed lower today.
  • Materials was the best performing sector, gaining 2.57%.
  • A-REIT was the worst performing sector today, losing 2.17%.
  • Volatility indicator A-VIX index was up 7.82% at 4.19 PM AEST.
  • The All-ordinaries Index gained 0.43%.

Newsmakers

PYC Therapeutics (ASX:PYC): The clinical pipeline of PYC Therapeutics now includes a third therapeutic programme for the treatment of Phelan McDermid Syndrome (PMS).

The new programme will concentrate on employing PYC's RNA therapy to treat Phelan McDermid Syndrome (PMS), a neurodevelopmental condition brought on by a lack of the gene SHANK3 in brain neuronal cells.

Meanwhile, shares of PYC closed trading flat at AU$0.070 apiece today.

Recce Pharmaceuticals (ASX:RCE): Recce Pharmaceuticals has revised its trial schedule, and many data read-outs are anticipated over the course of this year and the following year.

Later this year, Recce plans to dose the first participant in a phase 1b/2a multi-dose and early-stage sepsis research.

Meanwhile, shares of Recce closed trading at AU$0.68 apiece, up 5.38% on ASX today.

Image Source: © 2022 Kalkine Media ® 
Data Source- ASX website dated 27 September 2022

Bond yield

Australia’s 10-year Bond Yield stands at 4.04% as of 4.51 PM AEST.

In global markets

On Monday, September 26, Wall Street indices began the week in the red, weighed down by the growing growth fears that have so far dampened the traders' mood. Due to rising prices, an increase in policy rates, and other market concerns, investors appear to be unsure of their next move.

At the beginning of the current quarter, the market had experienced a summer surge, propelled by expectations for strong earnings and the possibility that the Federal Reserve may begin to scale back its hawkish monetary policies by the next year.

To combat the still-high inflation, the central bank may continue its strict monetary policies for "some time," according to the policymakers' hardline remarks. In addition, the Fed's jumbo-hike in policy rates last week has stoked doubts about the strength of the economy.

The S&P 500 fell 1.03% to 3,655.04. The Dow Jones was down 1.11% to 29,260.81. The NASDAQ Composite lost 0.60% to 10,802.92, and the small-cap Russell 2000 fell 1.41% to 1,655.88.

In Asia, Nikkei in Japan jumped 0.53%, Shanghai Composite in China gained 1.39% while the Hang Seng in Hong Kong decreased by 0.13% and the Asia Dow lost 1.49% and at 4.57 PM AEST.

In commodities markets

Crude Oil WTI was spotted trading at US$77.72/bbl while Brent Oil was at US$85.17/bbl at 4.59 PM AEST today.

Gold was at US$1635.74 an ounce, copper was at US$3.34/Lbs and iron ore was at US$99.50/T at 4.59 PM AEST on 15 September 2022.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.